AI in Scientific Research: Accelerating Discovery for Whom?

AI is accelerating scientific research in genuinely exciting ways. AlphaFold predicted protein structures that would have taken decades. AI-driven drug discovery is identifying candidates faster. Climate models are becoming more precise. Material science is finding new compounds.

This is real. And the redistribution question is just as real.

Who gets to use these tools? The labs that can afford the compute. DeepMind (Google) built AlphaFold. Microsoft and OpenAI partner with major research universities. The top 20 research institutions have AI capabilities that the rest — thousands of universities and research centers worldwide — cannot access.

The historical parallel is instrumentation. When electron microscopes were new, only the wealthiest labs had them. Research capacity concentrated around equipment. Eventually, shared facilities and falling costs democratized access — but it took decades, and the scientific landscape was permanently shaped by who had early access.

AI in research follows the same pattern but faster. The labs with AI tools publish first, attract talent, secure funding, and build compounding advantages. Labs without fall behind not because their scientists are less capable, but because their tools are.

The Global South dimension is stark. African universities produce a small fraction of global AI research — not for lack of talent, but for lack of compute. Indian research institutions struggle to run experiments that are routine at Stanford or MIT. The AI tools that accelerate discovery are overwhelmingly trained on, by, and for researchers in wealthy countries.

The redistribution angle:

• Who benefits: Well-funded research institutions (mostly US, UK, China), AI companies that partner with elite universities, pharmaceutical companies using AI drug discovery, researchers at institutions with compute access
• Who pays: Researchers at under-resourced institutions who fall further behind, Global South scientific communities, diseases and problems affecting poor populations (less likely to be AI research targets), scientific diversity (when a few labs dominate, research agendas narrow)
• What can be done: Create shared AI compute infrastructure for research (like CERN, but for AI). Fund open-source research AI tools. Establish AI research partnerships that include Global South institutions as equals, not subjects. Ensure AI-accelerated discoveries (especially in health) are accessible globally, not locked behind patents.

AlphaFold was released openly. That's the model. The question is whether it becomes the norm or the exception.

#AIResearch #ScienceAccess #GlobalSouth #Redistribution #OpenScience